Senate Cloture Vote Scheduled for FDA Nominee, Chamber May Consider Opioid Legislation

By Beth Goldstein on February 22, 2016 Posted in Healthcare

Legislative Activity Senate Cloture Vote Scheduled for FDA Nominee, Chamber May Consider Opioid Legislation On Monday, February 22, Senate Majority Leader Mitch McConnell (R-KY) has scheduled a cloture vote on the nomination of Dr. Robert Califf for Food and Drug Administration (FDA) Commissioner. Three Senators – Joe Manchin (D-WV), Ed Markey (D-MA), and Bernie Sanders … Continue Reading

Congress Awaits Health Provisions in President’s Budget; Health Bills Slated for House Floor Consideration; SAMHSA Releases Proposed Rule Focused on Confidentiality of Substance Use Disorder Patient Records

By Beth Goldstein on February 8, 2016 Posted in Healthcare

Legislative Activity Congress Awaits Health Provisions in President’s Budget On Tuesday, February 9, President Barack Obama will submit his FY 2017 Budget Request to Congress, which is expected to include several large-scale investments for the nation’s health. Last week, the White House released a “sneak preview” of the Budget, which includes: $755 million for cancer … Continue Reading

Health Bills Scheduled For House Floor Action; Medicare Premiums And Deductibles Announced

By Beth Goldstein on November 16, 2015 Posted in Healthcare

Legislative Activity Health Bills Scheduled For House Floor Action House Majority Leader Kevin McCarthy (R-CA) has announced that on Monday, November 16, the House will consider two health bills under suspension of the rules: S. 599, the Improving Access to Emergency Psychiatric Care Act, which extends and expands the Medicaid emergency psychiatric demonstration project; and … Continue Reading